Nordea Investment Management Portfolio holdings
AUM
$108B
1-Year Return
21.8%
This Quarter Return
+7.96%
1 Year Return
+21.8%
3 Year Return
+81.89%
5 Year Return
+144.92%
10 Year Return
+289.93%
AUM
$68.6B
AUM Growth
+$4.3B
(+6.7%)
Cap. Flow
+$921M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
23.43%
Holding
998
New
53
Increased
334
Reduced
492
Closed
45
Top Buys
| 1 |
Linde
LIN
|
+$549M |
| 2 |
Edison International
EIX
|
+$274M |
| 3 |
Conagra Brands
CAG
|
+$255M |
| 4 |
LKQ Corp
LKQ
|
+$210M |
| 5 |
Microsoft
MSFT
|
+$158M |
Top Sells
| 1 |
Republic Services
RSG
|
+$144M |
| 2 |
FedEx
FDX
|
+$139M |
| 3 |
Advanced Micro Devices
AMD
|
+$138M |
| 4 |
State Street
STT
|
+$135M |
| 5 |
S&P Global
SPGI
|
+$132M |
Sector Composition
| 1 | Technology | 28.48% |
| 2 | Healthcare | 16.99% |
| 3 | Consumer Discretionary | 10.39% |
| 4 | Industrials | 10.36% |
| 5 | Financials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Arch Capital
ACGL
$33.9B
| $1.74M | ﹤0.01% |
25,590
-393
| -2% | -$26.7K |
|
702
Quanta Services
PWR
$56B
| $1.72M | ﹤0.01% |
10,322
-113
| -1% | -$18.8K |
|
703
PG&E
PCG
$32B
| $1.72M | ﹤0.01% |
107,620
-1,578
| -1% | -$25.2K |
|
704
Alnylam Pharmaceuticals
ALNY
$59.6B
| $1.71M | ﹤0.01% |
8,643
+96
| +1% | +$19K |
|
705
First Bancorp
FBNC
$2.3B
| $1.71M | ﹤0.01% |
48,623
-960
| -2% | -$33.8K |
|
706
Extreme Networks
EXTR
$2.86B
| $1.71M | ﹤0.01% |
+92,777
| New | +$1.71M |
|
707
AvalonBay Communities
AVB
$27.7B
| $1.66M | ﹤0.01% |
10,033
-106
| -1% | -$17.5K |
|
708
TaskUs
TASK
$1.64B
| $1.65M | ﹤0.01% |
+113,215
| New | +$1.65M |
|
709
Universal Health Services
UHS
$11.8B
| $1.61M | ﹤0.01% |
12,856
+9,563
| +290% | +$1.2M |
|
710
Dover
DOV
$24.4B
| $1.61M | ﹤0.01% |
10,779
-2,071
| -16% | -$310K |
|
711
Aecom
ACM
$16.8B
| $1.59M | ﹤0.01% |
+18,946
| New | +$1.59M |
|
712
Insulet
PODD
$24.6B
| $1.58M | ﹤0.01% |
4,951
| – | – |
|
713
LyondellBasell Industries
LYB
$17.6B
| $1.58M | ﹤0.01% |
17,059
-442
| -3% | -$41K |
|
714
Sarepta Therapeutics
SRPT
$1.84B
| $1.58M | ﹤0.01% |
+11,510
| New | +$1.58M |
|
715
B2Gold
BTG
$5.68B
| $1.56M | ﹤0.01% |
+390,600
| New | +$1.56M |
|
716
Omnicom Group
OMC
$15.3B
| $1.51M | ﹤0.01% |
16,080
+465
| +3% | +$43.7K |
|
717
FMC
FMC
$4.73B
| $1.5M | ﹤0.01% |
12,306
+200
| +2% | +$24.3K |
|
718
CBRE Group
CBRE
$48.7B
| $1.48M | ﹤0.01% |
20,641
+1,007
| +5% | +$72K |
|
719
Pacific Biosciences
PACB
$375M
| $1.45M | ﹤0.01% |
+135,416
| New | +$1.45M |
|
720
Cooper Companies
COO
$13.7B
| $1.44M | ﹤0.01% |
15,532
+772
| +5% | +$71.8K |
|
721
Owens & Minor
OMI
$416M
| $1.44M | ﹤0.01% |
100,510
+35,202
| +54% | +$504K |
|
722
Clorox
CLX
$15.4B
| $1.44M | ﹤0.01% |
9,207
-278
| -3% | -$43.4K |
|
723
Apollo Global Management
APO
$76.9B
| $1.42M | ﹤0.01% |
22,830
-1,526
| -6% | -$94.7K |
|
724
Oneok
OKE
$44.9B
| $1.41M | ﹤0.01% |
22,487
-1,085
| -5% | -$68.2K |
|
725
Genuine Parts
GPC
$19.5B
| $1.41M | ﹤0.01% |
8,497
| – | – |
|